$0.37 Earnings Per Share Expected for Genpact Limited (G) This Quarter

Analysts expect Genpact Limited (NYSE:G) to post earnings of $0.37 per share for the current fiscal quarter, according to Zacks Investment Research. Seven analysts have provided estimates for Genpact’s earnings. The lowest EPS estimate is $0.34 and the highest is $0.38. Genpact reported earnings of $0.31 per share during the same quarter last year, which indicates a positive year over year growth rate of 19.4%. The business is scheduled to announce its next quarterly earnings report after the market closes on Thursday, May 3rd.

According to Zacks, analysts expect that Genpact will report full year earnings of $1.73 per share for the current year, with EPS estimates ranging from $1.72 to $1.74. For the next financial year, analysts forecast that the firm will report earnings of $1.95 per share, with EPS estimates ranging from $1.92 to $1.99. Zacks’ EPS averages are a mean average based on a survey of sell-side research analysts that follow Genpact.

How to Become a New Pot Stock Millionaire

Genpact (NYSE:G) last released its quarterly earnings data on Monday, February 12th. The business services provider reported $0.43 EPS for the quarter, topping the Zacks’ consensus estimate of $0.41 by $0.02. Genpact had a net margin of 9.61% and a return on equity of 22.75%. The firm had revenue of $734.41 million during the quarter, compared to analysts’ expectations of $723.55 million. During the same period in the previous year, the business posted $0.43 earnings per share. The company’s revenue for the quarter was up 7.7% compared to the same quarter last year.

G has been the subject of a number of research reports. Zacks Investment Research downgraded Genpact from a “buy” rating to a “hold” rating in a report on Tuesday, January 9th. Citigroup dropped their target price on Genpact from $39.00 to $37.50 and set a “buy” rating for the company in a report on Tuesday, February 13th. Cantor Fitzgerald reissued a “buy” rating and set a $36.00 target price on shares of Genpact in a report on Tuesday, February 13th. JPMorgan Chase dropped their target price on Genpact from $38.00 to $37.00 and set a “neutral” rating for the company in a report on Wednesday, February 14th. Finally, BMO Capital Markets lifted their target price on Genpact to $35.00 and gave the stock a “market perform” rating in a report on Tuesday, February 13th. One research analyst has rated the stock with a sell rating, three have given a hold rating and seven have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $34.65.

Shares of G traded down $0.04 during midday trading on Friday, reaching $31.86. 88,808 shares of the stock were exchanged, compared to its average volume of 784,313. Genpact has a twelve month low of $23.51 and a twelve month high of $34.79. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.71 and a current ratio of 1.71. The company has a market capitalization of $6,125.55, a P/E ratio of 21.41, a P/E/G ratio of 2.04 and a beta of 0.60.

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 21st. Investors of record on Friday, March 9th were paid a $0.075 dividend. This represents a $0.30 dividend on an annualized basis and a yield of 0.94%. The ex-dividend date of this dividend was Thursday, March 8th. This is an increase from Genpact’s previous quarterly dividend of $0.06. Genpact’s payout ratio is 20.13%.

In related news, insider Arvinder Singh sold 22,690 shares of the business’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $33.95, for a total value of $770,325.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director James C. Madden sold 4,270 shares of the business’s stock in a transaction dated Thursday, February 15th. The shares were sold at an average price of $30.92, for a total value of $132,028.40. The disclosure for this sale can be found here. 1.41% of the stock is owned by insiders.

Hedge funds have recently bought and sold shares of the stock. American International Group Inc. acquired a new position in Genpact during the fourth quarter worth about $114,000. The Manufacturers Life Insurance Company grew its holdings in shares of Genpact by 7.5% during the second quarter. The Manufacturers Life Insurance Company now owns 6,508 shares of the business services provider’s stock worth $181,000 after purchasing an additional 455 shares during the last quarter. MML Investors Services LLC bought a new stake in shares of Genpact during the fourth quarter worth about $246,000. Koch Industries Inc. bought a new stake in shares of Genpact during the fourth quarter worth about $253,000. Finally, Visionary Asset Management Inc. bought a new stake in shares of Genpact during the third quarter worth about $232,000. 91.01% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: This report was originally posted by Week Herald and is the sole property of of Week Herald. If you are reading this report on another domain, it was illegally stolen and republished in violation of U.S. and international trademark & copyright legislation. The original version of this report can be accessed at https://weekherald.com/2018/04/20/0-37-earnings-per-share-expected-for-genpact-limited-g-this-quarter.html.

About Genpact

Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.

Get a free copy of the Zacks research report on Genpact (G)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply